This study is looking at different doses of a medication called Misoprostol to help start labor (induction of labor) in pregnant people who have morbid obesity (a Body Mass Index or BMI of 40 or higher). The goal is to see if one dose of Misoprostol (25 mcg or 50 mcg, given vaginally every 4 hours) works better to help achieve a vaginal delivery. This is important because morbid obesity can make it harder to have a vaginal delivery, sometimes leading to a C-section. Researchers hope to find a way to improve vaginal delivery rates and reduce surgical risks for these patients. The study plans to enroll 162 participants and is currently recruiting. You may be able to join if you are 18 or older, speak English or Spanish, are between 34 and 42 weeks pregnant with a single baby, and have a BMI of 40 or higher.

Study design

This is a randomized, controlled, double-blind study comparing two different doses of Misoprostol. It plans to enroll 162 participants.

What's involved

Participants will receive either 25 mcg or 50 mcg of vaginal Misoprostol every 4 hours. The study measures the time from the start of labor induction until complete cervical dilation.

Compensation

Not stated in the trial record.

Follow-up

Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.